Quick Answer
Oscar Health, Inc. reported Net Income Loss of -$443.15 million for the year ending 2025.
- Oscar Health, Inc. showed a decrease of -1,842.5% in Net Income Loss from 2024 to 2025.
- This data is from Oscar Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: -$96.88 million | Q2 2020: -$40.94 million | Q3 2020: -$79.13 million | Q1 2021: -$88.88 million | Q2 2021: -$73.32 million | Q3 2021: -$211.48 million | Q1 2022: -$75.15 million | Q2 2022: -$112.16 million | Q3 2022: -$192.91 million | Q1 2023: -$39.77 million | Q2 2023: -$15.53 million | Q3 2023: -$65.40 million | Q1 2024: $177.37 million | Q2 2024: $56.21 million | Q3 2024: -$54.60 million | Q1 2025: $275.27 million | Q2 2025: -$228.36 million | Q3 2025: -$137.45 million.
- Over the full 7 years of available data (2019 to 2025), Oscar Health, Inc.'s Net Income Loss has declined by 69.7%.
- Historical annual values: Fiscal year 2025: -$443.15 million | Fiscal year 2024: $25.43 million | Fiscal year 2023: -$270.73 million | Fiscal year 2022: -$606.28 million | Fiscal year 2021: -$572.61 million | Fiscal year 2020: -$406.83 million | Fiscal year 2019: -$261.18 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: